Results 91 to 100 of about 1,888 (198)

Postoperative analgesic efficacy of preemptive and postoperative lornoxicam in femoropopliteal bypass surgery

open access: yesAğrı
Objectives: In this study, we analyzed the effect of the application time of intravenous (IV) lornoxicam in preventing postoperative pain. Methods: This placebo-controlled study was conducted on 72 patients undergoing elective femoropopliteal bypass ...
Demet Sergin   +4 more
doaj   +1 more source

Lornoxicam versus nitroglycerine as adjuvants to lidocaine in intravenous regional anesthesia by using a single forearm tourniquet

open access: yesAl-Azhar Assiut Medical Journal, 2018
Background Intravenous regional anesthesia (IVRA) is an old anesthetic technique for surgical procedures on the upper and lower limbs. It is a safe and effective type of anesthesia for hand surgery of 1 h duration or less. There are many modifications of
Mohamed Abdel Gawad Abdel Halim   +1 more
doaj   +1 more source

Efficacy of ibuprofen versus lornoxicam after third molar surgery: a randomized, double-blind, crossover pilot study [PDF]

open access: yes, 2018
Purpose: The aim of this study is to compare the analgesic efficacy and tolerability of a pre-emptive/post-surgery 4-day regimen of oral ibuprofen 400mg with that of lornoxicam 8mg. Methods: Sixteen patients received ibuprofen or lornoxicam, respectively,
Mutzbauer, Till   +2 more
core  

Lornoxicam use to reduce the pain associated with propofol injection

open access: yesLibyan Journal of Medicine, 2017
Aim: To investigate the efficacy of lornoxicam in the prevention of the pain associated with propofol injection. Material and method: Approval for this study was granted by the ethics committee of our hospital.
Nihal Başak   +3 more
doaj   +1 more source

FORMULATION AND EVALUATION OF LIQUISOLID COMPACTS OF LORNOXICAM [PDF]

open access: yes, 2019
Objective: Objective of the present investigation was to enhance the solubility and dissolution rate of poorly water-soluble drug lornoxicam using liquisolid technique with comparative determination of in vitro release profile of liquisolid compacts and ...
GAIKWAD, SNEHALATA L., Mokashi, Asma A.
core   +1 more source

No clinically relevant effect of lornoxicam intake on acenocoumarol pharmacokinetics and pharmacodynamics

open access: yes, 1999
OBJECTIVE: To investigate the effect of lornoxicam co-administration on acenocoumarol pharmacokinetics and pharmacodynamics. METHODS: In an open crossover study, six healthy male volunteers received racemic acenocoumarol (10 mg) orally without/with ...
von Felten, A.   +4 more
core  

Design and evaluation of lornoxicam bilayered tablets for biphasic release

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2012
The objective of the present investigation was to develop bilayered tablets of lornoxicam to achieve biphasic release pattern. A bilayered tablet, consisting of an immediate and controlled release layer, was prepared by direct compression technique.
Songa Ambedkar Sunil   +4 more
doaj  

Photochemical and DNA degradation studies on tenoxicam, lornoxicam, and their photolysis products

open access: yes, 2017
Elghamry I, El-Ayaan U, Youssef MM, Al-Shihry S, Letzel M, Mattay J. Photochemical and DNA degradation studies on tenoxicam, lornoxicam, and their photolysis products. Monatshefte für Chemie.
Mattay, Jochen   +5 more
core   +1 more source

Possibilities of using of lornoxicam in the treatment of pain in rheumatic diseases

open access: yesСовременная ревматология
Nonsteroidal anti-inflammatory drugs (NSAIDs) occupy one of the central positions in the multimodal control of acute and chronic musculoskeletal pain and have broad indications, including rheumatic diseases.
L. I. Alekseeva   +3 more
doaj   +1 more source

Spectrophotometric determination of lornoxicam in pharmaceutical preparations

open access: yes, 2014
The method of spectrophotometric determination of lornoxicam based on the extraction of its ion associate with basic polymethine dye Astrafloxin was developed. The extractant is a mixture of isooctane and dichloroethane in 3,5:1,5 volume ratio.
Кормош, Ж.О.   +2 more
core  

Home - About - Disclaimer - Privacy